Hypertension Clinical Trial
To study mechanisms of excess coronary ischemia secondary to alterations in autoregulation and arteriolar vasoreactivity in Black Americans with hypertension, varying degree of left ventricular hypertrophy, and angiographically normal or mildly diseased coronary arteries.
BACKGROUND:
Although studies in 1992 with a sufficient number of minority patients were sparse, those
available suggested that Black Americans had a higher case fatality from coronary heart
disease, but lesser amounts of atherosclerotic coronary artery disease. A possible
explanation for this apparent paradox was that myocardial ischemia might be more prevalent
with less coronary artery atherosclerosis in Black Americans because of comorbid diseases or
differences in coronary physiology. This could be secondary to excess hypertension and left
ventricular hypertrophy in Black Americans but might also have been related to intrinsic or
acquired differences in coronary artery autoregulation and vasoreactivity leading to
depression in coronary blood flow and reserve.
DESIGN NARRATIVE:
The intracoronary Doppler flow velocity guidewire together with quantitative coronary
angiography was used to study changes in coronary blood flow in blacks secondary to
pharmacologic provocateurs known to induce arteriolar vasodilation. White Americans with
similar demographic characteristics and equivalent amount of ventricular hypertrophy and
coronary disease were similarly studied in a parallel fashion for comparison. A control
group of normal white and Black Americans were studied to detect unexpected intrinsic
differences. Both endothelium dependent and independent induction of coronary arteriolar
vasodilation were studied. In 25 percent of patients with endothelium dependent defects in
arteriolar vasodilation, retesting was performed after intracoronary infusion of L-arginine,
the precursor of endothelium dependent relaxing factor. Finally, the possibility of a
rightward shift in coronary artery autoregulation in chronic hypertension was investigated.
This finding would necessitate that the lower limit of autoregulation occurred at higher
diastolic pressures, resulting in a drop-off of coronary perfusion at normal physiologic
pressures and ischemia.
The study completion date listed in this record was obtained from the "End Date" entered in
the Protocol Registration and Results System (PRS) record.
;
N/A
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |